|
 |
|
7405 Industrial Road
Florence, KY 41042
P 800.877.7405
F 859.525.7654 |
|
|
|
Offering extraordinary value repeatedly over time is what it takes to achieve the level of trust you would expect in a successful supplier partnership.
This customer, headquartered in Indianapolis, Indiana is the largest pharmaceutical company in the world with over 46,000 employees worldwide. They produce and market products in over 130 countries that treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions.
One of their Business Units, faced the challenge of having its marketing personnel, its creative agency and its commercial printer based in three different regional locations. Increased competition and changing market conditions placed increased pressure to reduce lead times and reduce overall production costs.
Nielsen incorporated an "online" proofing solution into its workflow in early 2004. This solution allowed the creative agency to electronically place all print-ready files for Nielsen's retrieval and eliminate the need for overnight delivery of CDs, lasers, etc. Automatic notification of a new pending file allowed Nielsen to quickly make a fully ripped proof available over the web. This allowed the creative agency and client to review, annotate and approve proofs, all without receiving hard copy proofs.
Art material and hard copy proof delivery costs have been eliminated entirely. This has reduced the overall production cost associated with each marketing project, and has also removed 2-3 days from each project's production cycle.
- For the this one division, overall production costs have been reduced by an average of $200 per project
- An average of 2-3 days have been shaved off of each print project due to art and proofs not being sent via couriers and overnight deliveries
- In November, 2004 the cusotmer began to incorporate this same electronic upload and proof workflow into the production model for all print collateral for its entire US affiliate - - the projected annual savings for this could total almost $500,000, and allow quicker time to market in an increasingly more competitive US drug market
|
| |
|
